| Trial ID: | L7141 |
| Source ID: | NCT01527747
|
| Associated Drug: |
Saxagliptin
|
| Title: |
Effects of DPP-4 Inhibition on Triglycerides
|
| Acronym: |
|
| Status: |
SUSPENDED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes|Hypertriglyceridemia
|
| Interventions: |
DRUG: Saxagliptin
|
| Outcome Measures: |
Primary: Change in fasting and postprandial triglyceride concentrations, Comparison of 6 weeks of placebo vs 6 weeks of saxagliptin, baseline, 6 weeks | Secondary: Changes in glycemia, Comparison of 6 weeks of placebo vs 6 weeks of saxagliptin, baseline, 6 weeks
|
| Sponsor/Collaborators: |
Sponsor: Oregon Health and Science University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
15
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2012-01
|
| Completion Date: |
2024-12
|
| Results First Posted: |
|
| Last Update Posted: |
2023-04-07
|
| Locations: |
Oregon Health & Science University, Portland, Oregon, 97239, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01527747
|
